Back to search

Article

Membrane-anchored and tumor-targeted Il-12(attIL12) PBMC therapy for osteosarcoma

2022-03-02

Abstract excerpt

<h4>Background: </h4> Chimeric antigen receptor (CAR) T cell therapy has shown great promise for hematologic malignancies but requires a long duration of T-cell expansion, is associated with severe toxicity, and has limited efficacy for treating solid tumor. Methods To address these challenges, we generated a cell membrane-anchored and tumor-targeted interleukin-12 (attIL12) to arm peripheral blood mononuclear ce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
646f4a91-cb6c-51d7-a13e-eb74b9925cce
DOI
10.21203/rs.3.rs-1392663/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Membrane-anchored and tumor-targeted Il-12(attIL12) PBMC therapy for osteosarcomaDOI 10.21203/rs.3.rs-1392663/v1
Select a neighboring publication to make it the new centre.